BOTHELL, Wash., June 7 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will present at the 6th Annual Needham Biotechnology and Medical Technology Conference at the Palace Hotel in New York. John Hinson, chief executive officer, will discuss recent business accomplishments and related financial information regarding Cardiac Science during the Company’s presentation on Thursday, June 14, at 8:00 am Eastern Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)
Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company’s website at http://www.cardiacscience.com. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com for 90 days.
About Cardiac Science Corporation
Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor - defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China and Manchester, United Kingdom.
Company Contact: Mike Matysik Cardiac Science Corporation Chief Financial Officer 425-402-2009 Media Contact: EVC Group, Inc. Steve DiMattia 646-201-5445 Investor Contact: EVC Group, Inc. Douglas Sherk/Jenifer Kirtland 415-896-6820
Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comCardiac Science Corporation
CONTACT: Company, Mike Matysik, Chief Financial Officer of Cardiac ScienceCorporation, +1-425-402-2009; or Media, Steve DiMattia, +1-646-201-5445, orInvestors, Douglas Sherk or Jenifer Kirtland, +1-415-896-6820, all of EVCGroup, Inc., for Cardiac Science Corporation
Web site: http://www.cardiacscience.com/
